Since 2022, the American Diabetes Association has updated its Standards of Care to recommend GLP1 receptor agonists as a firstline therapy for T2D 2 , eroding older and cheaper generics like metformin, which marks a momentous and fundamental change in treatment
Additionally do not use metformin if you have type 1 diabetes mellitus or metabolic acidosis (acute or chronic)
doi:10.1210/clinem/dgab892
The total gray matter cortical volume shrank less as well [195, 196]
The retatrutide + cagrilintide stack is the most aggressive metabolic peptide combination community sources currently describe a triple-agonist GLP-1/GIP/glucagon backbone (retatrutide) layered with a long-acting amylin analog (cagrilintide)
Isoorientin upregulates the expression of SIRT1 and SIRT6 to effectively reduce oxidative stress, inflammation, and prevent cell apoptosis in the cisplatin-induced AKI mice model and RTECs treated with cisplatin